Journals / Laparoscopic Endoscopic Surgical Science / 2020 / Cilt: 27 - Sayı: 2

Helicobacter pylori incidence in upper gastrointestinal endoscopy biopsies

Pages
67–70
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prospective studies are neededto further investigate these findings.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The incidence of Helicobacter pylori (HP) has been investigated in several studies.
📊
Key Findings & Data:The aim of this study was to assess the clinical andpathological association of HP in gastric biopsies.Materials and Methods: Patients who underwent an upper gastrointestinal endoscopy at the general surgeryclinic between January 2014 and January 2015 were included in the study.
💡
Conclusion & Impact:Prospective studies are neededto further investigate these findings.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Özet

Introduction: The incidence of Helicobacter pylori (HP) has been investigated in several studies. The bacteria can cause many diseases, such as atrophic gastritis, ulcers, dyspepsia, and gastric adenocarcinoma.Therefore, it is important to look for HP even in individuals who do not have any macroscopic findings onendoscopy and pursue eradication in positive cases. The aim of this study was to assess the clinical andpathological association of HP in gastric biopsies.Materials and Methods: Patients who underwent an upper gastrointestinal endoscopy at the general surgeryclinic between January 2014 and January 2015 were included in the study. Hospital registry system data ofdemographic details, admission complaints, and endoscopic findings were evaluated retrospectively. Patients who had a malignancy or who underwent an emergency endoscopy for gastrointestinal bleeding wereexcluded from the study.Results: A total of 325 patients were included in the study. In the group, 185 (56.9%) were female and 140(43.1%) were male. The mean age was 58 years (range: 18–89 years). The most common complaint wasepigastric pain. Biopsies were taken from the gastric antrum in 295 of the patients. The mean number ofbiopsies was 1.5 (range: 1–5). Active gastritis was present in 245. In 111 of the patients, HP was moderatelyor strongly positive, in 91 cases it was mild, and in 43 of the patients, the result was negative. Of the 80patients without any gastritis, 4 had mild positive staining results in the final pathology reports, while 2 hadmoderate or severe findings (p<0.0001).Conclusion: Upper gastrointestinal endoscopy revealed a high probability of HP positivity in patients examined for gastritis. Routine biopsy may not be advisable in high–risk patients. Prospective studies are neededto further investigate these findings.

🔖

Cite This Article

TOLAN, H. K., CANBAK, T. (2020). Helicobacter pylori incidence in upper gastrointestinal endoscopy biopsies. Laparoscopic Endoscopic Surgical Science, Cilt: 27 - Sayı: 2, 67–70. https://ajindex.com/articles/345164

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742–5
  2. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643–54. 3. di Mario F, Stefani N, Bò ND, Rugge M, Pilotto A, Cavestro GM, et al. Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey. Dig Dis Sci 2005;50:2286–95
  3. Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J, et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet 2000;355:1665–9
  4. Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6–30
  5. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology 2016;151:51–69.e14
  6. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol 2017;112:212–39
  7. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013;62:34–42
  8. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992;33:16–20
  9. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005;11:791–6
  10. Chen LW, Chang LC, Hua CC, Hsieh BJ, Chen SW, Chien RN. Analyzing the influence of gastric intestinal metaplasia on gastric ulcer healing in Helicobacter pylori-infected patients without atrophic gastritis. BMC Gastroenterol 2017;17:1
  11. Shrestha R, Koirala K, Raj KC, Batajoo KH. Helicobacter pylori infection among patients with upper gastrointestinal symptoms: prevalence and relation to endoscopy diagnosis and histopathology. J Family Med Prim Care 2014;3:154–8
  12. Mujawar P, Nikumbh DB, Suryawanshi KH, Pagare PS, Surana A. Heli